The Latest Analyst Ratings for Surgery Partners
Portfolio Pulse from Benzinga Insights
Surgery Partners (NASDAQ:SGRY) has received mostly bullish ratings from analysts in the last quarter, with 3 bullish and 2 somewhat bullish ratings. The average 12-month price target for the company is $48.8, a decrease of 12.86% from the previous average of $56.00.
October 12, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Surgery Partners has received mostly bullish ratings from analysts, indicating a positive outlook for the company. However, the decrease in the average price target suggests some caution.
Analyst ratings are a key indicator of a company's potential performance. The majority bullish ratings for Surgery Partners suggest a positive sentiment towards the company. However, the decrease in the average price target could indicate some concerns about the company's future performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100